Major equity indices closed broadly lower, with the Dow Jones Industrial Average and S&P 500 falling despite a flat finish for the tech-heavy Nasdaq. Investors closely monitored Anthropic's landmark market debut, which established the Claude creator's valuation at approximately $1.5 trillion. Meanwhile, crude prices climbed after Iranian state media reported that two tankers struck naval mines in the Strait of Hormuz. In foreign exchange and metals trading, the dollar's recent rally stalled, while both spot gold and silver declined over one percent.
Key points
Global equity indices exhibited choppy trading and broad declines despite the highly anti…: Global equity indices exhibited choppy trading and broad declines despite the highly anticipated public arrival of major artificial intelligence firms.
Naval mine explosions involving tankers in the Strait of Hormuz immediately countered pre…: Naval mine explosions involving tankers in the Strait of Hormuz immediately countered previous market expectations of a crude oil surplus.
The U.S. dollar index paused its advance toward 19-month highs, holding flat at 103.81 al…: The U.S. dollar index paused its advance toward 19-month highs, holding flat at 103.81 alongside a slight euro advance.
Sources checked by our analysis pipeline: 1
NEW YORK/LONDON, Nov 19 : Stocks fell across the world on Thursday as Anthropic's market debut kept trading choppy, while oil prices rose as traders focused on lingering attacks on shipping in the Strait of Hormuz.
Europe's tech stocks and the Nasdaq ebbed and flowed with focus squarely on the Claude developer's IPO. Priced at $83 apiece, valuing Anthropic at about $1.5 trillion, it is the first major AI developer to go public. How it trades in the coming days and weeks will be heavily scrutinized to gauge the broader sentiment towards AI.
As of 1635 GMT, Anthropic shares had not yet traded.
"We can't underestimate the importance of this IPO. It sort of serves as a valuation for the wider AI ecosystem," said Fiona Cincotta, senior market analyst at StoneX.
The Dow Jones Industrial Average fell 0.97 per cent to 49,710.33, the S&P 500 fell 0.41 per cent to 7,293.42 and the Nasdaq Composite rose 1.16 points, or 0.01 per cent, to 24,431.04.
MSCI's gauge of stocks across the globe fell 0.55 per cent to 1,068.62, and the pan-European…
Market analysts at the investment firm have finalized their primary selection within the healthcare and drug industry. This strategic designation reflects the institution's formal evaluation process regarding pharmaceutical sector performance. Stakeholders track these institutional selections closely to gauge broader research sentiment across the evolving medical marketplace.
Market participants worry that a major public listing could overwhelm buyers in an environment that is already displaying signs of instability. When an influx of new shares outpaces the capital available to absorb them, broader valuation pressures can rapidly mount across the exchange.
Investor scrutiny intensified after Hunterbrook targeted the semiconductor firm's operational credibility and competitive posture against market rivals. The investment entity's critique focused heavily on questionable commercial arrangements and aggressive public commitments. These allegations immediately pressured the chipmaker's valuation as markets processed the potential risks to its ongoing business narrative.